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Transforming growth factor-b (TGF-b) plays a critical role in
the progression of renal fibrosis. The activity of TGF-b is
tightly controlled by various mechanisms, among which
antagonizing Smad-mediated gene transcription by
co-repressors represents one of the important components.
We investigated the expression, degradation, and
ubiquitination of Smad transcriptional co-repressors SnoN
(ski-related novel gene N) and Ski (Sloan-Kettering Institute
proto-oncogene) in renal fibrogenesis. We also studied the
involvement of Smad-ubiquitination regulatory factor 2
(Smurf2) in ubiquitination of SnoN protein. The kidneys of
mice with unilateral ureteral obstruction (UUO) and those of
sham-operated mice were used. Renal lesions and the
expression of TGF-b1, type I collagen, SnoN, Ski, and Smurf2
were examined by immunohistochemistry, Western blot,
and/or real-time reverse transcriptase-polymerase chain
reaction. Degradation and ubiquitination of SnoN/Ski
proteins were also investigated. The obstructed kidneys of
UUO mice showed progressive tubulointerstitial fibrosis, high
expression levels of TGF-b1, type I collagen, SnoN and Ski
mRNAs, and low levels of SnoN and Ski proteins. Both
degradation and ubiquitination of SnoN/Ski proteins were
markedly increased in the obstructed kidneys, in which
Smurf2 expression was increased. Smurf2 immunodepletion
in extracts of obstructed kidneys resulted in reduced
ubiquitination of SnoN. Our results suggest that the
reduction of SnoN/Ski proteins resulting from increased
ubiquitin-dependent degradation is involved in the
progression of tubulointerstitial fibrosis.
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Cytokines of the transforming growth factor-b (TGF-b)
family are multifunctional proteins that affect a variety of
biological processes, including the cell cycle, apoptosis,
differentiation, and extracellular matrix accumulation.1
Extensive studies have suggested that TGF-b plays a
significant role in the progression of renal fibrosis in clinical
and experimental kidney diseases.2
TGF-b signaling is transduced by transmembrane serine/
threonine kinase receptors, termed type I and type II
receptors, and intracellular mediators known as Smad. Upon
TGF-b stimulation, Smad2 and Smad3 are phosphorylated at
serine residues in the carboxyl-termini by the type I receptor.
Once phosphorylated, Smads 2/3 dissociate from the
receptor, bind to Smad4, and then enter the nucleus. In the
nucleus, activated Smad can interact with various general
transcriptional co-activators such as p300 or CBP (CREB-
binding protein), resulting in transcriptional activation.
Alternatively, they form transcriptionally inactive complexes
with co-repressors such as c-Ski (Sloan-Kettering Institute
proto-oncogene), SnoN (ski-related novel gene N), or c-Myc.
Thus, the relative levels of Smad transcriptional co-repressors
present inside the cell could determine the ultimate outcome
of a TGF-b response.3–5
Smad transcriptional co-repressors SnoN and Ski were
initially identified as unique proto-oncoproteins and
described to induce both oncogenic transformation and
terminal muscle differentiation when expressed at high levels.
The expression of SnoN and Ski is increased in human tumor
cells, indicating that TGF-b signaling is negatively regulated,
resulting in enhanced tumor proliferation.6,7 On the other
hand, it has been reported that the expression levels of SnoN
and Ski are decreased in renal fibrosis and therefore
profibrotic activity via TGF-b signaling is stimulated.8 It is
therefore suggested that distinctive regulation of cellular
levels of SnoN/Ski plays a role in the progression of various
diseases. However, the in vivo regulatory mechanism remains
to be elucidated.
The levels of several cellular proteins are modulated
dynamically by the ubiquitin–proteasome degradation
pathway.9,10 Not only Smads but also SnoN and Ski are
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regulated by this degradation pathway, and Smad-ubiquiti-
nation regulatory factor 2 (Smurf2), an E3 ubiquitin ligase, is
involved in the ubiquitin-dependent proteasomal degrada-
tion of SnoN, similar to Smad2 and Smad7.11 In the present
study, we investigated the expression of Smad transcriptional
co-repressors, SnoN and Ski, and the regulatory mechanisms
of these proteins by the ubiquitin–proteasome pathway in the
kidneys of mice with unilateral ureteral obstruction (UUO), a
model of kidney disease with progressive tubulointerstitial
fibrosis.
RESULTS
Progressive tubulointerstitial fibrosis and enhanced
expression of TGF-b1 and COL1 in obstructed kidneys
The obstructed kidneys of UUO mice showed progressive
tubulointerstitial fibrosis, tubular dilatation, and interstitial
mononuclear cell infiltration compared with the sham-
operated kidneys (Figure 1a). These changes were associated
with marked and time-dependent increases in the expression
of TGF-b1 mRNA (Figure 1b).
The expression of type I collagen (COL1) mRNA, a
representative TGF-b-responsive gene, was also significantly
higher in obstructed kidneys from day 3 than in sham-
operated kidneys (12.5-, 35.0-, 39.0-, and 54.8-fold increases
on days 3, 7, 14, and 28, respectively, in obstructed kidneys
compared with sham-operated kidneys; Figure 1c).
Reduction of SnoN/Ski proteins, but not mRNAs, in
obstructed kidneys
In sham-operated kidneys, SnoN/Ski proteins showed
moderate and persistent expression. In contrast, SnoN/Ski
proteins gradually but significantly decreased in a time-
dependent manner in obstructed kidneys of UUO mice
(Figure 2a and b). This finding was further confirmed by
immunohistochemical analysis. Significant nuclear immuno-
reactivity for SnoN and Ski proteins was noted in tubular
epithelial cells in sham-operated kidneys, and immuno-
reactivity for SnoN protein was also detected in the
cytoplasm of tubular epithelial cells. In contrast, immuno-
reactivity for SnoN and Ski proteins was markedly decreased
in the obstructed kidneys of UUO mice (Figure 2c).
To investigate whether the reduction in SnoN/Ski proteins
was the result of downregulation of SnoN/Ski mRNAs, we
evaluated the mRNA expression of SnoN/Ski by real-time
reverse transcriptase-polymerase chain reaction (RT-PCR). In
contrast to the significant deceases of both proteins, the
expression of SnoN/Ski mRNAs was upregulated in the
obstructed kidneys from day 7 compared with the sham-
operated kidneys (Figure 2d). These results suggest that the
reduction of SnoN/Ski proteins in the obstructed kidneys
could be caused by enhanced protein degradation.
Increased degradation activity against endogenous SnoN/Ski
proteins in obstructed kidneys
To confirm the enhancement of SnoN/Ski protein degrada-
tion in the obstructed kidneys of UUO mice, we subjected
renal extracts to in vitro degradation assay. Degradation of
endogenous SnoN/Ski proteins was increased in renal
extracts prepared from the obstructed kidneys at day 7
(Figure 3a and b), when the level of both proteins was
decreased (Figure 2a). In contrast, no significant reduction of
SnoN/Ski proteins was noted in the renal extracts prepared
from the sham-operated kidneys. Furthermore, the degrada-
tion of endogenous SnoN/Ski proteins was prevented by the
addition of proteasome inhibitor, MG132 (Figure 3a). These
results indicate enhanced proteasome-mediated degradation
of SnoN and Ski proteins in the UUO-induced fibrotic
kidneys.
Increased ubiquitination activity directed against exogenous
SnoN/Ski proteins in obstructed kidneys
To examine whether the ubiquitin–proteasome system is
involved in the increased degradation of SnoN and Ski
proteins in the obstructed kidneys of UUO mice, we
investigated the in vitro ubiquitination activity directed
against the immunopurified hemagglutinin (HA)-tagged
SnoN and Ski proteins. HA-tagged SnoN or Ski protein
was mixed with renal extracts obtained from obstructed,
intact contralateral, or sham-operated kidneys. When using
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Figure 1 | Histopathological changes and enhanced expression of
TGF-b1 and COL1 in obstructed kidneys. (a) Representative data of
Masson’s trichrome staining of sham-operated kidney (Sham) and
unilateral ureteral obstructed kidney (UUO) on day 14. Note the
progressive development of tubulointerstitial fibrosis, tubular
dilatation, and interstitial mononuclear cell infiltration in obstructed
kidney. Images are shown at original magnification  200 . (b) The
ratios of TGF-b1 mRNA/GAPDH mRNA in sham-operated kidneys (&)
and obstructed kidneys on days 3, 7, 14, and 28 (’). TGF-b1 mRNA
expression was significantly increased in obstructed kidneys
compared with sham-operated kidneys. (c) Ratios of COL1 mRNA/
GAPDH mRNA in sham-operated kidneys (&) and obstructed kidneys
on days 3, 7, 14, and 28 (’). COL1 mRNA expression was significantly
increased in obstructed kidneys compared with sham-operated
kidneys. Data are mean7s.e.m. values of six mice in each group.
*Po0.05 compared with sham-operated kidneys. #Po0.01 compared
with sham-operated kidneys.
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anti-HA antibody to detect the degenerated HA-tagged SnoN
protein, significant smeared bands of degenerated HA-tagged
SnoN protein were observed in the renal extracts prepared
from the obstructed kidneys of UUO mice (Figure 4a, lanes
3–6). Smeared bands were also noted in renal extracts
prepared from the obstructed kidneys when using anti-
ubiquitin antibody to detect the polyubiquitinated proteins
(Figure 4a, lanes 10–13). In contrast, faint bands were
observed when HA-tagged SnoN protein was incubated with
renal extracts prepared from the contralateral kidneys of
UUO mice and from the sham-operated kidneys (Figure 4a,
lanes 1, 2, 8, and 9). No significant bands were observed
when the anti-HA-immunoprecipitate derived from mock-
transfected human embryonic kidney (HEK)293 cells as a
negative control was incubated with renal extracts prepared
from the obstructed kidneys at day 7 (Figure 4a, lanes 7 and
14). These results strongly suggest that the smeared bands
were polyubiquitinated HA-tagged SnoN proteins.
Similar polyubiquitination activity directed against the
immunopurified HA-tagged Ski protein was also noted in
renal extracts obtained from the obstructed kidneys of UUO
mice (Figure 4b, lanes 3–6 and 10–13). These results indicate
enhanced ubiquitination activities for SnoN and Ski proteins
in the UUO-induced fibrotic kidneys.
Increased expression of Smurf2 in obstructed kidneys
Smurf2 protein was weakly expressed in renal extracts
obtained from the sham-operated kidneys. In the obstructed
kidneys of UUO mice, marked expression of Smurf2 protein
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Figure 2 | SnoN and Ski expression in obstructed kidneys.
(a) Western blot analysis of SnoN and Ski proteins in renal extracts
prepared from the obstructed kidneys at indicated days, showing a
gradual reduction of SnoN/Ski contents in obstructed kidneys
compared with sham-operated kidneys. (b) Densitometric analysis of
SnoN/Ski proteins detected by Western blot analysis. Significant
decreases in both proteins were noted in obstructed kidneys (’)
compared with sham-operated kidneys (&). (c) Representative data
of immunohistochemistry for SnoN and Ski in sham-operated and
obstructed kidneys on day 14. Nuclear staining for both proteins was
noted in tubular epithelial cells (arrows). SnoN was also evident in
the cytoplasm of tubular epithelial cells (arrowheads). However,
immunoreactivity for SnoN and Ski proteins was markedly decreased
in obstructed kidneys. No significant immunoreactivity was observed
in sections of sham-operated kidneys when non-immune sera were
used instead of anti-SnoN or anti-Ski antibody (control). Images are
shown at original magnification  400. (d) Ratios of SnoN mRNA/
GAPDH mRNA or Ski mRNA/GAPDH mRNA in sham-operated (&) and
obstructed kidneys (’) at indicated days. In contrast to the levels of
SnoN and Ski proteins, their mRNA levels were significantly enhanced
in obstructed kidneys from day 7 compared with sham-operated
kidneys. Data are mean7s.e.m. values of six mice in each group.
*Po0.05 compared with sham-operated kidneys. #Po0.01 compared
with sham-operated kidneys.
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Figure 3 | SnoN- and Ski-degradation activity in obstructed
kidneys. (a, left panel) Renal extracts prepared from sham-operated
kidneys and obstructed kidneys on day 7 after UUO were mixed with
the reaction buffer, incubated for 0–16 h at 371C, and the reacted
mixtures were subjected to immunoblot analysis to detect the
degradation of endogenous SnoN and Ski proteins using anti-SnoN
or anti-Ski antibody. (Right panel) In vitro degradation assay of
endogenous SnoN and Ski in renal extracts was also performed for
8 h, with or without 1 proteasome inhibitor, 0.25 mM MG132.
Enhanced degradation of SnoN and Ski in obstructed kidneys was
completely prevented by the addition of the proteasome inhibitor.
(b) The SnoN/Ski protein signals in the left panel of (a) were
quantified by densitometry. The densitometric ratios were calculated
relative to the densitometric values at zero time in each group.
Degradation of endogenous SnoN and Ski proteins occurred in renal
extracts prepared from mice with UUO. In contrast, no significant
reduction in SnoN and Ski proteins was noted in renal extracts
prepared from sham-operated mice.
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was noted at day 3 and it was further increased thereafter in
almost inverse proportion to the level of SnoN (Figure 5a). In
the previous study, we also demonstrated a progressive
increase in Smurf2 mRNA expression in the obstructed
kidneys.12
Effects of immunodepletion of Smurf2 on ubiquitination of
SnoN and Ski
In the obstructed kidneys, significant smeared bands were
observed when HA-tagged SnoN protein was incubated with
the control renal extracts, which had not been immuno-
depleted of Smurf2 (Figure 5c, lanes 3 and 4). On the other
hand, the intensity of the bands was markedly decreased
when HA-tagged SnoN protein was incubated with Smurf2-
immunodepleted renal extracts (Figure 5c, lanes 5 and 6). In
sham-operated kidneys, no significant bands were detected
when HA-tagged SnoN protein was incubated with Smurf2-
immunodepleted renal extracts or with control renal extracts
(Figure 5c, lanes 1 vs 2). In contrast, no marked differences in
the intensity of smeared bands of polyubiquitinated HA-
tagged Ski proteins were noted between renal extracts
obtained from the obstructed kidneys with and without
Smurf2 immunodepletion (Figure 5c, lanes 9, 10 vs 11, 12).
These results suggest that the ubiquitination activity against
SnoN, but not Ski, was at least partially mediated by Smurf2
in UUO-induced fibrotic kidneys.
DISCUSSION
There is increasing evidence that TGF-b is a key mediator of
the progression of chronic renal disease.1,2 Tubulointerstitial
fibrosis is a final common pathway leading to end-stage renal
damage in various types of diseases, and its severity correlates
with renal prognosis.13 The mouse model of UUO is well
characterized, and is associated with tubulointerstitial
fibrosis, and TGF-b1 is known to play a critical role in this
process.14 TGF-b-mediated fibrosis is positively regulated by
receptor-regulated Smads 2/3 and it is known that phos-
phorylated Smads 2/3 translocate to the nucleus and
thereafter regulate transcriptional responses of TGF-b
target genes.3
Downregulation of TGF-b signaling is carried out in part
by a feedback mechanism involving induction of the
inhibitory Smad7 protein, which can prevent phosphoryla-
tion of receptor-activated Smads 2/3 through receptor
binding.4 Consistent with this concept, we previously
demonstrated that the TGF-b/Smads signaling system was
upregulated consistent with a decrease in inhibitory Smad7
protein resulting from ubiquitin-dependent proteasomal
degradation, which was followed by increased nuclear
accumulation of phosphorylated Smads 2/3 in mice with
obstructive nephropathy.12 In addition, recent studies have
shown the involvement of various transcriptional factors, co-
activators, and co-repressors in the regulation of the target
genes of Smad complexes.15,16 However, little is known about
the mechanisms that amplify the transcription of TGF-b-
responsive genes involved in tissue fibrogenesis.
The results of the present study showed that mice with
UUO exhibited progressive renal fibrosis associated with
increased expression levels of TGF-b1, COL1, SnoN and Ski
mRNAs, and Smurf2 protein, and at the same time
diminished levels of SnoN and Ski proteins. Both the
degradation and ubiquitination activities directed against
SnoN and Ski proteins were markedly enhanced in the renal
extracts of obstructed kidneys and the addition of a
proteasome inhibitor inhibited the degradation of SnoN
and Ski. Taken together, it is conceivable that the reduction of
SnoN and Ski proteins caused by ubiquitin-dependent
degradation is involved in the progression of renal fibrosis
after obstructive injury.
Smad transcriptional co-repressors SnoN and Ski have
been identified as proto-oncogenes and have been shown to
work as negative regulators in TGF-b signaling via interaction
with Smad proteins.17–19 Several mechanisms have been
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Figure 4 | Ubiquitination assays of SnoN and Ski in obstructed
kidneys. (a) Renal extracts prepared from the contralateral kidneys
(CLK) of UUO on day 7, from the sham-operated kidneys (Sham), and
from the obstructed kidneys on days 3, 7, 14, and 28 (UUO) were
incubated with immunopurified HA-tagged SnoN protein for 60 min
at 371C. The assay products were subjected to immunoblot analysis
using anti-HA antibody (12CA5; upper panel) or anti-ubiquitin
antibody (1B3; lower panel), separately. Significant smeared bands of
polyubiquitinated SnoN protein were observed when HA-SnoN
protein was incubated with renal extracts from obstructed kidneys
(lanes 3–6 and 10–13), but the band were faint in the renal extracts
from CLK and Sham (lanes 1 and 8 and 2 and 9, respectively).
Furthermore, no notable bands were observed when
anti-HA-immunoprecipitated protein, which was derived from
mock-transfected HEK293 cells as a negative control, was
incubated with renal extracts from obstructed kidneys on day 7
(mock, lanes 7 and 14). (b) Similar smeared bands of
polyubiquitinated Ski protein were also detected in renal extracts
of obstructed kidneys at indicated days (upper and lower panels,
lanes 3–6 and 10–13).
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proposed concerning the inhibitory role of SnoN and Ski in
Smad-mediated gene transcription. SnoN and Ski bind to
Smad4 and interfere with the interaction between Smad4 and
the activated Smads 2/3, and disrupt the active heteromeric
complex formed between Smad4 and Smads 2/3. In addition,
SnoN and Ski interact directly with various transcriptional
co-repressors such as the nuclear hormone receptor co-
repressor (N-CoR) and mammalian Sin3 ortholog (mSin3A),
and may be a component of the histone deacetylase complex
that restrains gene transcription. SnoN and Ski also prevent
Smads from binding to the transcriptional co-activator p300/
CBP. These mechanisms may operate together causing
repression of Smad function by SnoN and Ski.15,20 It is
therefore conceivable that the cellular levels of SnoN and Ski
may be important determinants of ultimate TGF-b responses,
which could regulate the intensity and duration of
TGF-b signals.
At present, the mechanisms that regulate the expression of
SnoN and Ski are not fully understood. SnoN expression is
strongly induced by TGF-b itself,21 although Ski expression is
not affected by TGF-b.22 On the other hand, TGF-b
treatment itself leads to rapid and marked reduction in
SnoN and Ski proteins, mediated by the ubiquitin–protea-
some degradation pathway.23 The ubiquitination and
subsequent proteasomal degradation of SnoN are mediated
by two ubiquitin ligases, Smurf2 and anaphase-promoting
complex; however, the ubiquitin ligase for Ski has not been
identified.24
Smurf2 was first identified as an homologous to E6-AP
C-terminus (HECT) type E3 ubiquitin ligase, which induces
the ubiquitination and degradation of Smad1.25 Subse-
quently, it was reported that Smurf2 was recruited to TGF-
b receptor complex through Smad7 association, and
ubiquitinated to degrade those receptors.26 These findings
suggest that Smurf2 could be a negative regulator of TGF-b
signaling under certain conditions. On the other hand, Bonni
et al.11 demonstrated that Smurf2 ubiquitinates to degrade
SnoN through activated Smad2. Asano et al.27 also reported
that the Smurf2-mediated inhibitory effect on TGF-b
signaling was impaired in scleroderma fibroblasts. Taken
together, it seems conceivable to consider that the role of
Smurf2 on the TGF-b signaling may be modified in disease
processes such as scleroderma and renal fibrosis.
Recently, Yang et al.8 demonstrated that SnoN and Ski
protein levels decreased progressively in the early stages
of renal fibrosis and suggested that such low levels were
involved in the amplification of profibrotic TGF-b signaling,
resulting in the progression of renal fibrosis. However,
they did not quantify SnoN and Ski mRNA expression
levels, and thus it was not clear whether the decreases
in SnoN and Ski proteins in the fibrotic kidneys resulted
from transcriptional suppression of the expression of
these genes or post-transcriptional modification under
pathologic conditions. In the present study, we demon-
strated, for the first time, that the decreases in SnoN and Ski
proteins in the fibrotic kidneys were not caused by decreases
in their mRNA expression, but rather by accelerated
degradation of SnoN and Ski proteins mediated by the
ubiquitin–proteasome pathway. Because SnoN and Ski
function as Smad transcriptional antagonists, the accelerated
degradation of these proteins by the pathway could
contribute to the uncontrolled activity of TGF-b/Smads
and finally results in renal fibrosis.
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Figure 5 | Immunoblot analysis and effects of Smurf2
immunodepletion on ubiquitination activity against SnoN
and Ski. (a) Western blot analysis demonstrated that Smurf2 was
weakly expressed in sham-operated kidneys. In UUO, the increases of
Smurf2 were noted in almost inverse proportion to the levels of
SnoN. (b) Renal extracts from obstructed or sham-operated kidneys
(input) were pre-incubated with anti-Smurf2 antibody and protein
G–Sepharose. After centrifugation, the remnant amounts of Smurf2 in
the supernatants were checked by immunoblotting using
anti-Smurf2 antibody (aSmurf2), and then subjected to the following
assay. As a control, we used renal extracts that had been
pre-incubated with rabbit immunoglobulin G (aIgG). (c, left panel)
In obstructed kidneys, significant smeared bands were observed
when HA-tagged SnoN was incubated with the control extracts that
had not been immunodepleted of Smurf2 (; lanes 3 and 4);
however, the bands were much weaker when HA-tagged SnoN was
incubated with Smurf2-immunodepleted extracts (þ ; lanes 5 and 6).
In sham-operated kidneys, no significant bands were detected (lanes
1 and 2). (Right panel) We also performed a similar ubiquitination
assay for Ski. No notable differences in the intensity of the bands
were observed between the control (; lanes 9 and 10) and the
Smurf2-immunodepleted extracts (þ ; lanes 11 and 12) in
obstructed kidneys.
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Furthermore, immunodepletion of Smurf2 from the
extracts of the obstructed kidneys resulted in reduction of
SnoN ubiquitination, suggesting that the enhanced SnoN
ubiquitination was mediated by Smurf2 in the obstructed
kidneys, at least in part, although Ski ubiquitination was not
affected by immunodepletion of Smurf2. We have recently
demonstrated that the expression of Smurf2 is rapidly
induced by TGF-b itself.28 Increased expression of TGF-b
in the obstructed kidneys may stimulate Smurf2 expression
to promote SnoN degradation as a negative regulator of TGF-
b/Smad signaling. However, we cannot rule out the possible
contribution of the pathway involving another ubiquitin
ligase, anaphase-promoting complex, in the ubiquitination of
SnoN, and decreased translation of SnoN and Ski may also
contribute to low levels of those proteins. The role of some
other co-repressors, such as c-Myc for Smad signaling, also
remains to be clarified.5
In conclusion, the present study suggests that the
reduction of SnoN and Ski proteins induced by ubiquitin-
dependent degradation is involved in the progression of renal
fibrosis in mice with obstructive injury. Further studies to
elucidate the regulatory mechanism of ubiquitin–proteasomal
degradation of intracellular TGF-b signaling may open up a
new strategy for controlling pathological TGF-b activity in
tissue fibrogenesis.
MATERIALS AND METHODS
Experimental animals and design
Male C57BL6/J mice, weighing 20–25 g at the start of the
experiment, were used (n¼ 30). Ureteral obstruction was achieved
by ligating the left ureter with 3-0 silk through a left lateral incision
as described previously.12 Sham-operated mice (n¼ 6) were used as
controls. Mice were killed at 3, 7, 14, or 28 days after operation (each
group; n¼ 6) and the obstructed kidneys were dissected out and
subjected to the studies described below. The experimental protocol
was approved by the Ethics Review Committee for Animal
Experimentation of Hamamatsu University School of Medicine.
Histopathological and immunohistochemical analyses
Kidney tissues were fixed in 4% paraformaldehyde in phosphate-
buffered saline and embedded in paraffin. Tissue sections (3mm
thick) were stained with Masson’s trichrome for histopathological
analysis. Immunoreactivity for SnoN and Ski proteins was
determined using a standard biotin–streptavidin–peroxidase method
as described previously.29,30 The primary antibodies were goat anti-
human SnoN (sc-9595; Santa Cruz Biotechnology, Santa Cruz, CA,
USA) and rabbit anti-human c-Ski (sc-9140; Santa Cruz Biotech-
nology). The secondary antibodies were affinity-purified biotiny-
lated donkey anti-goat or anti-rabbit immunoglobulin G (Cortex
Biochem, San Leandro, CA, USA). Sections incubated with non-
immune goat or rabbit sera instead of the primary antibodies were
used as negative controls. Nuclei were counterstained lightly with
hematoxylin.
Immunoblot analysis
Kidney tissues were extracted with Triton X-100 lysis buffer
containing 50 mM Tris-HCl (pH 7.5), 300 mM NaCl, 0.5% Triton
X-100, 1 mM phenylmethylsulfonyl fluoride, 1 mg/ml aprotinin, 1 mg/
ml leupeptin, 1 mg/ml pepstatin A, 0.1 mM sodium orthovanadate,
1 mM sodium fluoride and 10 mM b-glycerophosphate. These lysates
were homogenized and incubated for 30 min at 41C, and centrifuged
for 10 min at 9000 g. The resulting supernatants were used in the
immunoblot analysis. Equal amounts of proteins (40 mg) were
loaded for sodium dodecyl sulfate-polyacrylamide gel electrophor-
esis (SDS-PAGE) as described previously.29–31 The primary anti-
bodies were goat anti-human SnoN (Santa Cruz Biotechnology),
rabbit anti-human c-Ski (Santa Cruz Biotechnology), rabbit anti-
human Smurf2 (sc-25511; Santa Cruz Biotechnology), and mouse
monoclonal anti-b-actin (Sigma, St Louis, MO, USA). b-Actin was
used as an internal control. The band intensity was quantified using
National Institute of Health Image analysis software (Bethesda, MD,
USA).
RNA isolation and quantitative analysis of mRNA by real-time
RT-PCR
Total RNA was extracted from renal tissue using ISOGEN (Nippon
Gene Inc., Tokyo, Japan) according to the instructions provided by
the manufacturer. Reverse transcription of the RNA was performed
using the first-strand cDNA synthesis kit (Roche, Mannheim,
Germany) and 1 mg of total RNA. For real-time PCR, the Light
Cycler PCR and detection system (Roche) were used for amplifica-
tion and online quantification. All PCR experiments were performed
using the QuantiTectTM SYBR Green PCR kit purchased from Qiagen
(Tokyo, Japan). The PCR primer sequences were as follows: mouse
TGF-b1 (sense: 50-CCTGAGTGGCTGTCTTTTGACG-30 and anti-
sense 50-AGTGAGCGCTGAATCGAAAGC-30), mouse a1 type I
collagen (COL1), (sense: 50-AGAGCATGACCGATGGATTCC-30 and
antisense 50-TTGCCAGTCTGCTGGTCCATG-30), mouse SnoN
(sense: 50-GAGGAGCAGGAGAAAATGG-30 and antisense 50-GAAT
CACGCTTGCTTGTG-30), mouse c-Ski (sense: 50-TGACTCTGGAC
ACAGCAGGA-30 and antisense 50-GAGAGGACAGCGAGGACAAG-
30), and mouse glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) (sense: 50-TGCACCACCAACTGCTTAG-30 and antisense
50-GAGGCAGGGATGATGTTC-30). Data analysis was performed
using the Light Cycler software (version 3.3.9) provided by Roche.
The ratios of TGF-b1, COL1, SnoN, and Ski mRNAs to GAPDH
mRNA were calculated in each sample.
Degradation assays for SnoN and Ski
To investigate the degradation activity of SnoN and Ski in the
kidneys, we conducted in vitro degradation assays for endogenous
SnoN and Ski in renal extracts prepared from obstructed kidneys on
day 7 and those from sham-operated kidneys. Obstructed and
sham-operated kidneys were extracted with Triton X-100 lysis buffer
as described in the above section on immunoblot analysis. The
resulting supernatants were used in the degradation assay. Renal
extracts, 15 mg in 15 ml reaction buffer (50 mM Tris-HCl (pH 8.3),
5 mM MgCl2, 2 mM dithiothreitol, 5 mM adenosine-5
0-triphosphate,
and 2 mg/ml ubiquitin), were incubated for 0, 4, 8, or 16 h at 371C.
After incubation, each sample was subjected to SDS-PAGE, followed
by immunoblot analysis with anti-SnoN and anti-c-Ski antibodies
(Santa Cruz Biotechnology). The degradation assays were also
performed with 1 proteasome inhibitor (0.25 mM MG132).
Preparation of HA-tagged SnoN and Ski proteins
HEK293 cells were grown in Dulbecco’s modified Eagle’s medium
with 10% fetal bovine serum at 371C in a 95% air–5% CO2
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atmosphere. N-terminal HA-tagged pact-SnoN and N-terminal HA-
tagged pact-c-Ski expression vectors were kindly provided by Dr S
Ishii (Riken Tsukuba Institute, Ibaraki, Japan). HEK293 cells were
transfected with these expression vectors using the calcium
phosphate method. As a control, N-terminal HA-tagged pact-vector
lacking SnoN or c-Ski was used. The cells were extracted with Triton
X-100 lysis buffer after incubation for 48 h.12,31 The cell lysates
(2000mg/200 ml) were immunoprecipitated with 3 mg anti-HA
monoclonal antibody (12CA5; Roche) and 30 ml protein G–Sephar-
ose beads (Amersham Biosciences, Uppsala, Sweden) for 3 h at 41C.
The resulting immunoprecipitates were washed thoroughly three
times with cold lysis buffer, and then used as the substrates for in
vitro ubiquitination assays.
In vitro SnoN- and Ski-ubiquitination assays
To determine whether the ubiquitin-dependent degradation of
SnoN and Ski proteins was enhanced in the fibrotic kidneys, we
performed an in vitro assay of ubiquitination activity directed
against exogenous HA-tagged SnoN/Ski proteins. Renal extracts
obtained from obstructed and sham-operated kidneys with Triton
X-100 lysis buffer were centrifuged for 8 h at 100 000 g, and the
resulting supernatants (S100) were used in the ubiquitination assay,
as described previously.12,31,32 In brief, the renal extracts were mixed
with the ubiquitination mixture31 and the immunopurified HA-
tagged proteins described in the above section. After incubation for
60 min at 371C, the protein G–Sepharose beads trapping ubiquiti-
nated HA-SnoN/Ski proteins were again washed thoroughly three
times by the Triton X-100 buffer to remove other ubiquitinated pro-
teins from the reacted mixtures, and then subjected to SDS-PAGE,
followed by immunoblot analysis. On detecting the polyubiquiti-
nated HA-tagged SnoN/Ski, anti-HA and anti-ubiquitin immuno-
blots were performed separately using the same reacted mixtures
after the washing.
Next, we investigated the involvement of Smurf2 in the
ubiquitination of SnoN/Ski in fibrotic kidneys. For this purpose,
we determined the ubiquitination activity in renal extracts that had
been immunodepleted of Smurf2. For immunodepletion, renal
lysates were pre-incubated with 4 mg anti-Smurf2 antibody (Santa
Cruz Biotechnology) and 40 ml protein G–Sepharose beads for 3 h at
41C and were centrifuged for 3 min at 2000 g. The resulting
supernatants were used in the Smurf2-immunodepleted ubiquitina-
tion assay. As a control, renal extracts pre-incubated with non-
immune rabbit immunoglobulinG instead of anti-Smurf2 antibody
were used. The levels of remnant Smurf2 in the immunodepleted
renal extracts were checked by immunoblotting using anti-Smurf2
antibody.
Statistical analysis
All values were expressed as mean7s.e.m. Differences between
groups were examined for statistical significance using analysis of
variance. When a significant difference was found, further statistical
analysis was performed using the Scheffe F-test between the two
groups. P-values less than 0.05 denoted the presence of a statistically
significant difference.
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